Guangdong VTR Bio-Tech Co., Ltd.

SZSE:300381 Stock Report

Market Cap: CN¥3.7b

Guangdong VTR Bio-Tech Management

Management criteria checks 4/4

Guangdong VTR Bio-Tech's CEO is Derong Zhou, appointed in Aug 2022, has a tenure of 2.75 years. directly owns 0.26% of the company’s shares, worth CN¥9.51M. The average tenure of the management team and the board of directors is 2.8 years and 4.3 years respectively.

Key information

Derong Zhou

Chief executive officer

CN¥922.7k

Total compensation

CEO salary percentagen/a
CEO tenure2.8yrs
CEO ownership0.3%
Management average tenure2.8yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 30
Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) Looks Inexpensive But Perhaps Not Attractive Enough

Guangdong VTR Bio-Tech's (SZSE:300381) Soft Earnings Are Actually Better Than They Appear

May 02
Guangdong VTR Bio-Tech's (SZSE:300381) Soft Earnings Are Actually Better Than They Appear

There's No Escaping Guangdong VTR Bio-Tech Co., Ltd.'s (SZSE:300381) Muted Revenues Despite A 35% Share Price Rise

Apr 30
There's No Escaping Guangdong VTR Bio-Tech Co., Ltd.'s (SZSE:300381) Muted Revenues Despite A 35% Share Price Rise

Guangdong VTR Bio-Tech Co., Ltd.'s (SZSE:300381) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Mar 08
Guangdong VTR Bio-Tech Co., Ltd.'s (SZSE:300381) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

CEO

Derong Zhou (56 yo)

2.8yrs

Tenure

CN¥922,700

Compensation

Mr. Derong Zhou is President of Guangdong VTR Bio-Tech Co., Ltd. from August 26, 2022. He joined the Guangdong VTR Bio-Tech Co., Ltd.on November 17, 2017. He was Executive VP & Board Secretary of Guangdon...

Leadership Team

NamePositionTenureCompensationOwnership
Derong Zhou
President & Director2.8yrsCN¥922.70k0.26%
CN¥ 9.5m
Shiliang Ding
Assistant to Presidentno dataCN¥563.30kno data
Guohua Feng
Vice President21.3yrsCN¥821.50k0.080%
CN¥ 3.0m
Hongfang Du
Vice Presidentno dataCN¥729.50k0.14%
CN¥ 5.3m
Xiaoping Huang
Financial Director1.1yrsno datano data
Xichun Pu
Supervisor & Accounting Supervisorno datano datano data
Shanmin Zhu
Secretary1.1yrsno datano data
Binfeng Zhuang
Vice President6.1yrsno datano data
Yangyuan Li
Vice President2.8yrsno datano data

2.8yrs

Average Tenure

44yo

Average Age

Experienced Management: 300381's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Derong Zhou
President & Director7.5yrsCN¥922.70k0.26%
CN¥ 9.5m
Xichun Pu
Supervisor & Accounting Supervisor10.6yrsno datano data
Qingying Dai
Non-Employee Supervisor11.9yrsno datano data
Shaomei Chen
Chairman7.5yrsCN¥1.20mno data
Depo Yang
Independent Director1.1yrsno datano data
Chaoqun Wu
Non Independent Director4.3yrsCN¥80.00kno data
Guancheng Chen
Non Independent Director4.3yrsCN¥270.40kno data
Dan Feng
Chairman of the Supervisory Boardno datano datano data
Zhe Ren
Independent Director1.1yrsno datano data
Ziqiang Yuan
Independent Director1.1yrsno datano data

4.3yrs

Average Tenure

53yo

Average Age

Experienced Board: 300381's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/17 17:40
End of Day Share Price 2025/05/16 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Guangdong VTR Bio-Tech Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jia ChenChangjiang Securities Co. LTD.
Xiao Bao LiuEverbright Securities Co. Ltd.
Baoping ZhangFounder Securities Co., Ltd.